31Jul
Department of Justice fines pharmaceutical company
Compliance Today (August 2020) - On May 7, the Department of Justice’s Antitrust Division announced a deferred prosecution agreement, in which Apotex Corp. agreed to pay a $24.1 million criminal penalty for price-fixing. The Florida-based company conspired with competitors to increase and maintain the price of pravastatin, a commonly prescribed cholesterol medication that lowers the risk of heart disease and stroke....
By:
Health Care Compliance Association (HCCA)
Related
- The covenant-lite share of European institutional loan issuance in 2019 reached 92 per cent - Eur...
Read More >
The global pandemic and the economic crisis are becoming opportunities to create, develop and promot...
Read More >
Even though it is less than 10 days before paid sick and safe time (PSST) ordinances in Dallas and S...
Read More >
Under the Family and Medical Leave Act of 1993 (FMLA), eligible employees of covered employers are e...
Read More >
The Subletting and Subcontracting Fair Practices Act (Public Contract Code section 4100 et seq.), al...
Read More >
Addressing a matter of first impression, the Iowa Supreme Court determined that “when a civil cause...
Read More >